Global Investigation of Clinical Implementation Strategies for <scp> <i>DPYD</i> </scp> Testing to Guide Fluoropyrimidine Therapy
Year: 2025
Type: article
Language: en
Topic: Colorectal Cancer Treatments and Studies
Authors and affiliations:
raw_author_name: Nihal El Rouby
raw_affiliation_strings: Division of Pharmacy Practice and Administrative Sciences, James L. Winkle College of Pharmacy University of Cincinnati  Cincinnati Ohio USA
St. Elizabeth Healthcare  Edgewood Kentucky USA
raw_author_name: Christina L. Aquilante
raw_affiliation_strings: Colorado Center for Personalized Medicine University of Colorado Anschutz Medical Campus  Aurora Colorado USA
Department of Pharmaceutical Sciences University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences  Aurora Colorado USA
raw_author_name: Salma A. Bargal
raw_affiliation_strings: Department of Medicine and Program for Personalized and Genomic Medicine University of Maryland School of Medicine  Baltimore Maryland USA
raw_author_name: Larisa H. Cavallari
raw_affiliation_strings: Center for Pharmacogenomics and Precision Medicine and Department of Pharmacotherapy and Translational Research University of Florida  Gainesville Florida USA
raw_author_name: Julio D. Duarte
raw_affiliation_strings: Center for Pharmacogenomics and Precision Medicine and Department of Pharmacotherapy and Translational Research University of Florida  Gainesville Florida USA
raw_author_name: Kelly Gunderson
raw_affiliation_strings: Aaron W Perlman Center for Cerebral Palsy Cincinnati Children's Hospital Medical Center  Cincinnati Ohio USA
raw_author_name: Tinashe Mazhindu
raw_affiliation_strings: Department of Oncology African Institute for Biomedical Sciences and Technology and University of Zimbabwe  Harare Zimbabwe
raw_author_name: Mohamed Nagy
raw_affiliation_strings: Department of Pharmaceutical Services and Sciences Children's Cancer Hospital  Cairo Egypt
Personalized Medication Management Unit Children's Cancer Hospital  Cairo Egypt
raw_author_name: Xiaoyan Nie
raw_affiliation_strings: Department of Pharmacy Administration and Clinical Pharmacy Peking University  Beijing China
raw_author_name: D. Grace Nguyen
raw_affiliation_strings: Atrium Health Wake Forest Baptist Comprehensive Cancer Center  Winston‐Salem North Carolina USA
Division of Cancer Pharmacology &amp; Pharmacogenomics Atrium Health Levine Cancer  Charlotte North Carolina USA
raw_author_name: Jai N. Patel
raw_affiliation_strings: Atrium Health Wake Forest Baptist Comprehensive Cancer Center  Winston‐Salem North Carolina USA
Division of Cancer Pharmacology &amp; Pharmacogenomics Atrium Health Levine Cancer  Charlotte North Carolina USA
raw_author_name: Todd C. Skaar
raw_affiliation_strings: Division of Clinical Pharmacology, Department of Medicine Indiana University School of Medicine  Indianapolis Indiana USA
raw_author_name: D. Max Smith
raw_affiliation_strings: Georgetown University Medical Center  Washington DC District of Columbia USA
MedStar Health  Columbia Maryland USA
raw_author_name: Sony Tuteja
raw_affiliation_strings: Division of Translational Medicine and Human Genetics, Department of Medicine Perelman School of Medicine  Philadelphia Pennsylvania USA
raw_author_name: Ron H. N. van Schaik
raw_affiliation_strings: Department of Clinical Chemistry Erasmus University Medical Center  Rotterdam the Netherlands
raw_author_name: J. Kevin Hicks
raw_affiliation_strings: Department of Oncologic Sciences, Morsani College of Medicine University of South Florida  Tampa Florida USA
Department of Pathology Moffitt Cancer Center  Tampa Florida USA
raw_author_name: The PGRN Implementation Working Group